academic article

• Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events..  JAMA neurology.  81:835-844. 2024
• Thinking Three-Dimensionally: A Self- and Externally-Controlled Approach to Screening for Drug-Drug-Drug Interactions Among High-Risk Populations..  Clinical pharmacology and therapeutics.  116:448-459. 2024
• Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease..  Parkinsonism & Related Disorders.  -. 2023
• Channeling of New Neuropsychiatric Drugs-Impact on Safety and Effectiveness Studies..  Neurotherapeutics.  20:375-388. 2023
• Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals..  Frontiers in pharmacology.  -. 2022
• Pharmacosafety of fluoroquinolone and macrolide antibiotics in the clinical care of patients with myasthenia gravis..  Muscle & nerve.  64:156-162. 2021
• Impact of Hospitalization and Medication Switching on Post-discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation..  Pharmacotherapy.  40:1022-1035. 2020